A Randomized Trial Evaluating EARLY Application of a Surfactant Dressing in Thermal Injury (EARLY) (EARLY)
Primary Purpose
Burns, Partial-thickness Burn
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
WSD
Dressed with bacitracin and petrolatum gauze
Sponsored by
About this trial
This is an interventional treatment trial for Burns focused on measuring EARLY, Randomized Clinical Trial, Surfactant, Dressing, Total Body Surface Area, Outcome Assessment, Thermal Burn Injuries
Eligibility Criteria
Inclusion Criteria:
- age ≥ 18 years old
- admitted within 24 hours of injury
- partial-thickness burn wounds on at least two non-contiguous areas of < 10% TBSA each and not involving face, fingers, toes, and perineum
- initial management assessed to require inpatient care
Exclusion Criteria:
- chemical, electrical, or inhalation injury
- pregnant
- incarcerated
- TBSA ≥ 20%
- wound expected to heal within 7 days
- patient or authorized representative unable or unwilling to consent
- unable to consent within 24 hours of injury
Sites / Locations
- Regional One HealthRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Intervention
Control
Arm Description
Dressed with WSD and petrolatum gauze
Dressed with bacitracin and petrolatum gauze
Outcomes
Primary Outcome Measures
Percent difference (cm2) in partial-thickness wound conversion
Tissue salvage
Secondary Outcome Measures
Time to 95% re-epithelialization
Healing time
Daily pain scores for each wound care session
Pain via Numeric Rating Scale (0-10; 0 having no pain and 10 being the worst possible pain)
Incidence of burn wound infection and cellulitis
Infection up to day of initial excision or day of discharge
Hospital costs
Cost of care during inpatient stay
Full Information
NCT ID
NCT04880655
First Posted
May 3, 2021
Last Updated
June 1, 2022
Sponsor
University of Tennessee
Collaborators
Medline Industries
1. Study Identification
Unique Protocol Identification Number
NCT04880655
Brief Title
A Randomized Trial Evaluating EARLY Application of a Surfactant Dressing in Thermal Injury (EARLY)
Acronym
EARLY
Official Title
A Randomized, Controlled Study Evaluating a Surfactant-based Wound Dressing for Tissue Salvage and Reduction in Surgical Burden
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 3, 2021 (Actual)
Primary Completion Date
June 2023 (Anticipated)
Study Completion Date
June 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Tennessee
Collaborators
Medline Industries
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
The purpose of this study is to test the following hypotheses:
Early use of water-soluble surfactant dressing (WSD) on partial-thickness burn wounds will result in tissue salvage and reduce surgical burden.
Early use of WSD on partial-thickness burn wounds will result in faster healing.
Use of WSD on partial-thickness burn wounds will result in less painful wound care.
Early use of WSD on partial-thickness burn wounds will result in less infection.
Early use of WSD on partial-thickness burn wounds will result in lower hospital costs.
Detailed Description
Surfactant-based wound dressings have been utilized in chronic, non-healing wounds and small burn wounds to soften and aid removal of wound debris. In vitro data suggest enhanced healing properties are due the ability to stabilize and potentially reseal plasma membranes, thereby, retaining cellular integrity and enhance wound healing. Improved cellular viability and functionality has also been established in heat-shock, ionizing radiation, and electrical injury models. In one rat model, topically suffused mesentery demonstrated improved microvascular flow and reduction in the number of abnormally flowing microvessels following thermal injury. Intravenous administration has been studied in several disease states. In thermal injury, intravenous administration has shown potential to improve blood flow and reduce the zone of coagulation. Further, surfactant-based wound dressings are non-ionic and may facilitate removal, sensitize, or prevent bacterial biofilms. Biofilms are an evolved, protective mechanism bacteria utilize to reduce antimicrobial efficacy. Removal or penetration of biofilms is essential for bacterial eradication. There is little evidence demonstrating the efficacy of early use of a WSD for treating partial-thickness burn wounds.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Burns, Partial-thickness Burn
Keywords
EARLY, Randomized Clinical Trial, Surfactant, Dressing, Total Body Surface Area, Outcome Assessment, Thermal Burn Injuries
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
27 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Dressed with WSD and petrolatum gauze
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Dressed with bacitracin and petrolatum gauze
Intervention Type
Device
Intervention Name(s)
WSD
Intervention Description
Post debridement and within 24 hours of injury, wound care and WSD applied daily
Intervention Type
Device
Intervention Name(s)
Dressed with bacitracin and petrolatum gauze
Intervention Description
Post debridement and within 24 hours of injury, wound care and dressing applied daily
Primary Outcome Measure Information:
Title
Percent difference (cm2) in partial-thickness wound conversion
Description
Tissue salvage
Time Frame
Up to 14 days
Secondary Outcome Measure Information:
Title
Time to 95% re-epithelialization
Description
Healing time
Time Frame
Up to 28 days
Title
Daily pain scores for each wound care session
Description
Pain via Numeric Rating Scale (0-10; 0 having no pain and 10 being the worst possible pain)
Time Frame
Up to 7 days
Title
Incidence of burn wound infection and cellulitis
Description
Infection up to day of initial excision or day of discharge
Time Frame
Up to 28 days
Title
Hospital costs
Description
Cost of care during inpatient stay
Time Frame
Up to 28 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age ≥ 18 years old
admitted within 24 hours of injury
partial-thickness burn wounds on at least two non-contiguous areas of < 10% TBSA each and not involving face, fingers, toes, and perineum
initial management assessed to require inpatient care
Exclusion Criteria:
chemical, electrical, or inhalation injury
pregnant
incarcerated
TBSA ≥ 20%
wound expected to heal within 7 days
patient or authorized representative unable or unwilling to consent
unable to consent within 24 hours of injury
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yvonne Shaw, RN
Phone
901-448-2714
Email
yshaw@uthsc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
David M. Hill, PharmD
Facility Information:
Facility Name
Regional One Health
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38103
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yvonne Shaw, RN
Email
yshaw@uthsc.edu
First Name & Middle Initial & Last Name & Degree
David M. Hill, PharmD
First Name & Middle Initial & Last Name & Degree
S. Ram Velamuri, MD
First Name & Middle Initial & Last Name & Degree
Kalyan Dadireddy, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27428718
Citation
Palumbo FP, Harding KG, Abbritti F, Bradbury S, Cech JD, Ivins N, Klein D, Menzinger G, Meuleneire F, Seratoni S, Zolss C, Mayer D. New Surfactant-based Dressing Product to Improve Wound Closure Rates of Nonhealing Wounds: A European Multicenter Study Including 1036 Patients. Wounds. 2016 Jul;28(7):233-40.
Results Reference
background
PubMed Identifier
18434836
Citation
Birchenough SA, Rodeheaver GT, Morgan RF, Peirce SM, Katz AJ. Topical poloxamer-188 improves blood flow following thermal injury in rat mesenteric microvasculature. Ann Plast Surg. 2008 May;60(5):584-8. doi: 10.1097/SAP.0b013e3181651661.
Results Reference
background
PubMed Identifier
7436067
Citation
Rodeheaver GT, Kurtz L, Kircher BJ, Edlich RF. Pluronic F-68: a promising new skin wound cleanser. Ann Emerg Med. 1980 Nov;9(11):572-6. doi: 10.1016/s0196-0644(80)80228-9.
Results Reference
background
PubMed Identifier
30895731
Citation
Chen R, Salisbury AM, Percival SL. In vitro cellular viability studies on a concentrated surfactant-based wound dressing. Int Wound J. 2019 Jun;16(3):703-712. doi: 10.1111/iwj.13084. Epub 2019 Mar 20.
Results Reference
background
PubMed Identifier
16533934
Citation
Maskarinec SA, Wu G, Lee KY. Membrane sealing by polymers. Ann N Y Acad Sci. 2005 Dec;1066:310-20. doi: 10.1196/annals.1363.018.
Results Reference
background
PubMed Identifier
10842638
Citation
Lee RC, Hannig J, Matthews KL, Myerov A, Chen CT. Pharmaceutical therapies for sealing of permeabilized cell membranes in electrical injuries. Ann N Y Acad Sci. 1999 Oct 30;888:266-73. doi: 10.1111/j.1749-6632.1999.tb07961.x.
Results Reference
background
PubMed Identifier
1584787
Citation
Lee RC, River LP, Pan FS, Ji L, Wollmann RL. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4524-8. doi: 10.1073/pnas.89.10.4524.
Results Reference
background
PubMed Identifier
16533935
Citation
Walsh AM, Mustafi D, Makinen MW, Lee RC. A surfactant copolymer facilitates functional recovery of heat-denatured lysozyme. Ann N Y Acad Sci. 2005 Dec;1066:321-7. doi: 10.1196/annals.1363.029.
Results Reference
background
PubMed Identifier
15302418
Citation
Greenebaum B, Blossfield K, Hannig J, Carrillo CS, Beckett MA, Weichselbaum RR, Lee RC. Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation. Burns. 2004 Sep;30(6):539-47. doi: 10.1016/j.burns.2004.02.009.
Results Reference
background
PubMed Identifier
11676555
Citation
Baskaran H, Toner M, Yarmush ML, Berthiaume F. Poloxamer-188 improves capillary blood flow and tissue viability in a cutaneous burn wound. J Surg Res. 2001 Nov;101(1):56-61. doi: 10.1006/jsre.2001.6262.
Results Reference
background
PubMed Identifier
29931339
Citation
Yang Q, Schultz GS, Gibson DJ. A Surfactant-Based Dressing to Treat and Prevent Acinetobacter baumannii Biofilms. J Burn Care Res. 2018 Aug 17;39(5):766-770. doi: 10.1093/jbcr/irx041.
Results Reference
background
PubMed Identifier
27212453
Citation
Yang Q, Larose C, Della Porta AC, Schultz GS, Gibson DJ. A surfactant-based wound dressing can reduce bacterial biofilms in a porcine skin explant model. Int Wound J. 2017 Apr;14(2):408-413. doi: 10.1111/iwj.12619. Epub 2016 May 22.
Results Reference
background
PubMed Identifier
30335643
Citation
Salisbury AM, Percival SL. Efficacy of a Surfactant-Based Wound Dressing in the Prevention of Biofilms. Adv Skin Wound Care. 2018 Nov;31(11):514-520. doi: 10.1097/01.ASW.0000544612.28804.34.
Results Reference
background
PubMed Identifier
30204575
Citation
Mayer D, Armstrong D, Schultz G, Percival S, Malone M, Romanelli M, Keast D, Jeffery S. Cell salvage in acute and chronic wounds: a potential treatment strategy. Experimental data and early clinical results. J Wound Care. 2018 Sep 2;27(9):594-605. doi: 10.12968/jowc.2018.27.9.594.
Results Reference
background
PubMed Identifier
32530755
Citation
Pittinger TP, Curran D, Hermans MH. The treatment of paediatric burns with concentrated surfactant gel technology: a case series. J Wound Care. 2020 Jun 1;29(Sup6):S12-S17. doi: 10.12968/jowc.2020.29.Sup6.S12.
Results Reference
background
PubMed Identifier
33472159
Citation
Pittinger T, Curran D, Hermans M. Treatment of Burns in Adult Patients With a Concentrated Surfactant Gel: A Real-life Retrospective Evaluation. Wounds. 2020 Dec;32(12):339-344.
Results Reference
background
PubMed Identifier
31166855
Citation
Kirsner RS, Amaya R, Bass K, Boyar V, Ciprandi G, Glat PM, Percival SL, Romanelli M, Pittinger TP. Effects of a surfactant-based gel on acute and chronic paediatric wounds: a panel discussion and case series. J Wound Care. 2019 Jun 2;28(6):398-408. doi: 10.12968/jowc.2019.28.6.398.
Results Reference
background
Learn more about this trial
A Randomized Trial Evaluating EARLY Application of a Surfactant Dressing in Thermal Injury (EARLY)
We'll reach out to this number within 24 hrs